tHEORetically Speaking
Menu Close
  • Home
  • Guest Bloggers
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

HExpo_RWE

Playing in the Real World Evidence Sandbox: Sharing, Teamwork, and Transparency

Posted on November 19, 2014 by Patti Peeples, R.Ph., Ph.D.

Is just playing in the same sandbox together an example of Real World Evidence (RWE) collaboration? Not really. So how exactly do you play nicely in the RWE ‘sandbox’, but really collaborate and actually get a project off the ground,… Continue Reading →

clinical trials, Digital marketing, HE-Xpo, HealthEconomics.Com, HEOR, HExpo_RWE, late phase research, Patti Peeples, pharmaceutical, pricing, Real-World Evidence, RWE, Virtual Conferences Allan Korn, Blue Cross and Blue Shield, clinical research, FDAMA 114, HE-Xpo, health care, HealthEconomics.Com, HEOR, HExpo_RWE, late phase research, Market Access, Nathan White, patients, patti peeples, payers, pharmaceutical, pricing, real world evidence, Real-world evidence, RWE, virtual conferences

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Subscribe for updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 68 other subscribers

Recent Posts

  • The 5 Numbers That Will Define Healthcare Value in 2021
  • Size Doesn’t Matter: A Small Biotech Plays Big with Payer Engagement
  • How Health Economics and Outcomes Researchers Can Help Defeat COVID-19
  • How Should a Safe and Effective COVID‑19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton
  • Educating the Next Leaders in Applied HEOR: Jefferson’s Unique Approach

Dr. Peeples Tweets!

HealthEconomics.Com | A Scientist.com CompanyFollow

HealthEconomics.Com | A Scientist.com Company
www_healtheconHealthEconomics.Com | A Scientist.com Company@www_healthecon·
3h

Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017 http://ow.ly/H3v350D9URI #Drugcosts #HEOR #pharma

Reply on Twitter 1350191039374626824Retweet on Twitter 1350191039374626824Like on Twitter 1350191039374626824Twitter 1350191039374626824
www_healtheconHealthEconomics.Com | A Scientist.com Company@www_healthecon·
5h

Fierce JPM Week Partner Content Hub http://ow.ly/1Cjn50D9UDD #HEOR #Pharma

Reply on Twitter 1350173054916288514Retweet on Twitter 1350173054916288514Like on Twitter 13501730549162885141Twitter 1350173054916288514
www_healtheconHealthEconomics.Com | A Scientist.com Company@www_healthecon·
5h

Read my latest #research on #wagedisparity in #HEOR, published with @SpringerNature in Pharmakoeconomics

Reply on Twitter 1350171426150641664Retweet on Twitter 1350171426150641664Like on Twitter 1350171426150641664Twitter 1350171426150641664
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2021 tHEORetically Speaking. All rights reserved.
Hiero by aThemes